PIEZO1 and myeloid sarcoma: In addition, other ion channels expressed in OPCs, such as Piezo1 and NCX3, have been identified as contributors to disease dynamics in various MS models, further supporting the therapeutic relevance of OPC ion channels in demyelinating conditions.